Heart shield? melatonin and vitamin d tested in breast cancer patients
NCT ID NCT07349459
First seen Jan 20, 2026 · Last updated May 13, 2026 · Updated 20 times
Summary
This study looks at whether taking melatonin or vitamin D can help prevent heart damage in women being treated for breast cancer with the drug doxorubicin. The trial will include 90 women aged 18 to 65 who are scheduled to receive doxorubicin. Researchers will measure heart function and blood markers to see if either supplement offers protection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DOXORUBICIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tanta University
Tanta, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.